Item 7.01 Regulation FD Disclosure

On January 15, 2020, executive management of ChemoCentryx, Inc. presented an updated corporate presentation at various meetings with investors and others. The corporate presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K, which is incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall expressly be set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits






(d) Exhibits




                  99.1     ChemoCentryx Investor Presentation

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses